{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:13:46Z","timestamp":1765232026671},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s11427-012-4362-3","type":"journal-article","created":{"date-parts":[[2012,8,29]],"date-time":"2012-08-29T09:47:43Z","timestamp":1346233663000},"page":"735-743","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Epstein-Barr virus infection on the development of multiple myeloma after liver transplantation"],"prefix":"10.1007","volume":"55","author":[{"given":"YeWei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HeWei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SuWen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TaiHong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DongLiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JingFeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JianFei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Yee","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,30]]},"reference":[{"key":"4362_CR1","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1182\/blood.V93.10.3157.410a40a_3157_3159","volume":"93","author":"J. R. Berenson","year":"1999","unstructured":"Berenson J R, Vescio R A. HHV-8 is present in multiple myeloma patients. Blood, 1999, 93: 3157\u20133159","journal-title":"Blood"},{"key":"4362_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1359-6101(03)00024-8","volume":"14","author":"G. A. Bishop","year":"2003","unstructured":"Bishop G A, Hostager B S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev, 2003, 14: 297\u2013309","journal-title":"Cytokine Growth Factor Rev"},{"key":"4362_CR3","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.162.5.2555","volume":"162","author":"L. K. Busch","year":"1999","unstructured":"Busch L K, Bishop G A. The EBV transforming protein, LMP1, mimics and cooperates with CD40 signaling in B lymphocyte. J Immunol, 1999, 162: 2555\u20132561","journal-title":"J Immunol"},{"key":"4362_CR4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00007890-199810270-00014","volume":"66","author":"T. V. Cacciarelli","year":"1998","unstructured":"Cacciarelli T V, Green M, Jaffe R, et al. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation, 1998, 66: 1047\u20131052","journal-title":"Transplantation"},{"key":"4362_CR5","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1182\/blood.V99.9.3411","volume":"99","author":"A. Challa","year":"2002","unstructured":"Challa A, Eulopulos A G, Holder M J, et al. Population depletion activates autonomous CD154-dependent survival in biopsy-like Burkitt\u2019s lymphoma cells. Blood, 2002, 99: 3411\u20133418","journal-title":"Blood"},{"key":"4362_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2141.1998.01031.x","volume":"103","author":"K. Clodi","year":"1998","unstructured":"Clodi K, Asgary Z, Zhao S, et al. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells. Br J Haematol, 1998, 103: 270\u2013275","journal-title":"Br J Haematol"},{"key":"4362_CR7","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1172\/JCI117089","volume":"93","author":"R. Fuleihan","year":"1994","unstructured":"Fuleihan R, Ramesh N, Horner A, et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest, 1994, 93: 1315\u20131320","journal-title":"J Clin Invest"},{"key":"4362_CR8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","volume":"91","author":"M. Hallek","year":"1998","unstructured":"Hallek M, Bergsagel P L, Anderson K C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood, 1998, 91: 3\u201321","journal-title":"Blood"},{"key":"4362_CR9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1074-7613(00)80281-2","volume":"6","author":"S. H. Hanissian","year":"1997","unstructured":"Hanissian S H, Geha R S. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity, 1997, 6: 379\u2013387","journal-title":"Immunity"},{"key":"4362_CR10","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1073\/pnas.1231363100","volume":"100","author":"K. Imadome","year":"2003","unstructured":"Imadome K, Shirakata M, Shimizu N, et al. CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation. Proc Natl Acad Sci USA, 2003, 100: 7836\u20137840","journal-title":"Proc Natl Acad Sci USA"},{"key":"4362_CR11","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1093\/emboj\/20.11.2641","volume":"20","author":"A. Kaykas","year":"2001","unstructured":"Kaykas A, Worringer K, Sugden B. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J, 2001, 20: 2641\u20132654","journal-title":"EMBO J"},{"key":"4362_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2184.2003.00276.x","volume":"36","author":"H. M. Oh","year":"2003","unstructured":"Oh H M, Oh J M, Choi S C, et al. An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. Cell Prolif, 2003, 36: 191\u2013197","journal-title":"Cell Prolif"},{"key":"4362_CR13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/381434a0","volume":"381","author":"C. P. Larsen","year":"1996","unstructured":"Larsen C P, Elwood E T, Alexander D Z, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature, 1996, 381: 434\u2013438","journal-title":"Nature"},{"key":"4362_CR14","doi-asserted-by":"crossref","first-page":"9948","DOI":"10.1074\/jbc.M110.185983","volume":"286","author":"K. M. Arcipowski","year":"2011","unstructured":"Arcipowski K M, Stunz L L, Graham J P, et al. Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1). J Biol Chem, 2011, 286: 9948\u20139955","journal-title":"J Biol Chem"},{"key":"4362_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11427-011-4147-0","volume":"54","author":"Z. Wang","year":"2011","unstructured":"Wang Z, Yang S, Zhou L, et al. Specific cellular immune responses in mice immunized with DNA, adeno-associated virus and adenoviral vaccines of Epstein-Barr virus-LMP2 alone or in combination. Sci China Life Sci, 2011, 54: 263\u2013266","journal-title":"Sci China Life Sci"},{"key":"4362_CR16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nm1045","volume":"10","author":"R. K. Mathur","year":"2004","unstructured":"Mathur R K, Awasthi A, Wadhone P, et al. Reciprocal CD40 signals through p38MAPK and ERK-1\/2 induce counteracting immune responses. Nat Med, 2004, 10: 540\u2013544","journal-title":"Nat Med"},{"key":"4362_CR17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00007890-200003150-00048","volume":"69","author":"D. Mutimer","year":"2000","unstructured":"Mutimer D, Kaur N, Tang H, et al. Quantification of Epstein-Barr virus DNA in the blood after adult liver transplantation. Transplantation, 2000, 69: 954\u2013959","journal-title":"Transplantation"},{"key":"4362_CR18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/00007890-199705150-00002","volume":"63","author":"M. A. Nalesnik","year":"1997","unstructured":"Nalesnik M A, Rao A S, Furukawa H, et al. Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients. Transplantation, 1997, 63: 1200\u20131205","journal-title":"Transplantation"},{"key":"4362_CR19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jgm.1412","volume":"12","author":"H. Xu","year":"2010","unstructured":"Xu H, Zhao G, Huang X, et al. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination. J Gene Med, 2010, 12: 97\u2013106","journal-title":"J Gene Med"},{"key":"4362_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.imlet.2004.03.004","volume":"93","author":"C. J. Qi","year":"2004","unstructured":"Qi C J, Zheng L, Zhou X, et al. Cross-linking of CD40 using anti-CD40 antibody, 5C11, has different effects on XG2 multiple myeloma cells. Immunol Lett, 2004, 93: 151\u2013158","journal-title":"Immunol Lett"},{"key":"4362_CR21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","volume":"121","author":"The International Myeloma Working Group.","year":"2003","unstructured":"The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Hematol, 2003, 121: 749\u2013757","journal-title":"Br J Hematol"},{"key":"4362_CR22","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3109\/10428190009148403","volume":"36","author":"A. W. Tong","year":"2000","unstructured":"Tong A W, Seamour B, Chen J, et al. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells. Leuk Lymphoma, 2000, 36: 543\u2013558","journal-title":"Leuk Lymphoma"},{"key":"4362_CR23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1126\/science.286.5438.300","volume":"286","author":"J. Uchida","year":"1999","unstructured":"Uchida J, Yasui T, Takaoka-Shichijo Y, et al. Mimicry of C40 signals by EBV LMP1 in B lymphocyte responses. Science, 1999, 286: 300\u2013303","journal-title":"Science"},{"key":"4362_CR24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"L. S. Young","year":"2004","unstructured":"Young L S, Rickinson A B. Epstein-Barr virus: 40 years on. Nat Rev Cancer, 2004, 4: 757\u2013768","journal-title":"Nat Rev Cancer"},{"key":"4362_CR25","doi-asserted-by":"crossref","first-page":"7070","DOI":"10.1002\/j.1460-2075.1996.tb01098.x","volume":"15","author":"U. Zimber-Strobl","year":"1996","unstructured":"Zimber-Strobl U, Kempkes B, Marschall G, et al. Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J, 1996, 15: 7070\u20137078","journal-title":"EMBO J"},{"key":"4362_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11427-010-4122-1","volume":"54","author":"J. Cao","year":"2011","unstructured":"Cao J, Shen C, Zhang J, et al. Comparison of alternative extraction methods for secretome profiling in human hepatocellular carcinoma cells. Sci China Life Sci, 2011, 54: 34\u201338","journal-title":"Sci China Life Sci"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-012-4362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-012-4362-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-012-4362-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T13:19:05Z","timestamp":1687699145000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-012-4362-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["4362"],"URL":"https:\/\/doi.org\/10.1007\/s11427-012-4362-3","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}